SCN2A
- issue: account for one-sixth of patients and half of the diagnoses provided by the PAGEM. CONCLUSION: These results suggest that a gene-panel approach is an efficient first-tier test for the genetic diagnosis of Mendelian epileptic disorders. In a near futu - volume: French patients with ""drug-resistant epilepsies with seizure-onset in the first two-years of life"" can be - pages: SYNGAP1.